157 related articles for article (PubMed ID: 30358208)
1. RANKL, OPG, TRAIL, KRas, and c-Fos expression in relation to central lymph node metastases in papillary thyroid carcinoma.
Deligiorgi MV; Mahaira H; Eftychiadis C; Kafiri G; Georgiou G; Theodoropoulos G; Konstadoulakis MM; Zografos E; Zografos GC
J BUON; 2018; 23(4):1029-1040. PubMed ID: 30358208
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease.
Sood SK; Balasubramanian S; Higham S; Fernando M; Harrison B
World J Surg; 2011 Sep; 35(9):1984-92. PubMed ID: 21748518
[TBL] [Abstract][Full Text] [Related]
3. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
4. OPG, RANK and RANK ligand expression in thyroid lesions.
Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
[TBL] [Abstract][Full Text] [Related]
5. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
Tang T; Li J; Zheng L; Zhang L; Shi J
Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
8. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
[TBL] [Abstract][Full Text] [Related]
10. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
11. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.
Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952
[TBL] [Abstract][Full Text] [Related]
12. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
13. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D
Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482
[TBL] [Abstract][Full Text] [Related]
14. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
Hao Y; Jin C; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
[TBL] [Abstract][Full Text] [Related]
16. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract][Full Text] [Related]
17. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma.
Kim SK; Kwon AY; Back K; Park I; Hur N; Lee JH; Choe JH; Kim JH; Oh YL; Kim JS
Ann Surg Oncol; 2017 Sep; 24(9):2617-2623. PubMed ID: 28685355
[TBL] [Abstract][Full Text] [Related]
19. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Zhao H; Li H; Huang T
J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
[TBL] [Abstract][Full Text] [Related]
20. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
